News In Brief
This article was originally published in The Gray Sheet
Boston Scientific touts stent wins. Biomet settles foreign bribery charges. Roche ups Illumina bid. Derma Sciences acquires MedEfficiency.
You may also be interested in...
The company came under a Department of Justice inquiry for overseas bribery in 2012, and new allegations in 2014 have delayed a final close-out of the case. The formal agreements expired on March 26, but Biomet says it expects the investigation to continue.
Potential growth drivers identified by the firm during its April 19 first-quarter earnings call include the Ingenio family of pacemakers and BSX-manufactured Promus Element everolimus-eluting stent system.
Illumina rejects Roche’s increased bid. Medtronic settles shareholder suit over Infuse. HeartWare buys WorldHeart for $8 million. More news briefs.